MV ≤15 days n= 12 | MV >15 days n= 28 | P value | |
---|---|---|---|
Sex, males/females | 7/12 | 16/28 | NS |
Age, years | 50 ± 20 | 56 ± 21 | NS |
SAPS II | 35 ± 25 | 25 ± 15 | NS |
DSH, days | 5.0 ± 6.3 | 6.2 ± 7.2 | NS |
Delay to improvement, days | 12 ± 11 | 28 ± 30 | 0.03 |
ICU length of stay, days | 17 ± 10 | 75 ± 99 | 0.002 |
Sodium at admission, mmol/L | 136 ± 3.9 | 133 ± 3.5 | 0.04 |
Dysautonomy, number | 8/12 | 16/28 | NS |
EMG subtype, percentage of demyelinating subtype | 63 | 82 | NS |
Acquired infection, percentage of patients | 75 | 96 | NS |
Lack of foot flexion, number (percentage) | |||
At admission | 4 (34) | 18 (65) | 0.01 |
At the end of immunotherapy | 5 (42) | 23 (82) | 0.001 |
Independent ambulation at follow-up, percentage | 53 | 49 | NS |
Deaths, number | 2 | 2 | - |